Trial intelligence / Profile preview

Autologous peripheral blood cell transplantation with platelet-rich plasma for vesicoureteral reflux

IRCT20170417033489N4Phase 2Completed

Sponsor
Mashhad University of Medical Sciences
Start
May 2014
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of platelet-rich plasma in vesicoureteral reflux (VUR), sponsored by Mashhad University of Medical Sciences. Primary endpoint: vesicoureteral reflux cure. Started May 2014; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

vesicoureteral reflux (VUR)

Beyond the preview

Go deeper on IRCT20170417033489N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170417033489N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call